Brain: The new study reported a number of neurological symptoms in patients with new coronary pneumonia.

!--:PAGE:"----- In a new study, the newly described case report adds to growing evidence that COVID-19 infection can lead to serious, long-term neurological complications -- including inflammation, insanity, delirium, nerve damage and stroke--- even in patients with mild infections with few other symptomsit also points out that in some cases, these neurological effects are the first manifestations of the diseaserelated findings were published online July 8, 2020 in the journal Brain, with the title "The emerging spectrum of COVID-19 colesy: clinical, radioc and laboratory findings"images from Brain, 2020, doi: 10.1093/brain/awaa240in the paper, researchers from research institutions such as University College London and others noted an increase in cases of a potentially fatal disease called acute dispersal encephalomyelitis ( Acute periamymyitis , ADEM) this springAlthough ADEM is usually diagnosed in young children after a viral infection, the researchers say they observed two to three ADEM cases per week in patients with coronavirus infection between April and May of this yearnormally, University College London Hospital observes about two ADEM cases per month in adults"We're looking at the way COVID-19 affects the brain, which we haven't seen before in other viruses," said Michael Zandi, a consultant neurologist at University College London Hospital, whothe paper."what we've observed in some ADEM patients and others is that you may have severe neurological symptoms, you may be very ill, but in fact only mild lung disease"COVID-19 is primarily a respiratory disease that attacks the lungs, but it also exhibits seemingly unrelated symptoms, such as loss of taste and sense of smell or memory loss, which can last for months after the initial diagnosisthese strange phenomena suggest that it is the cause of the nervous systemstudy details the neurological symptoms of 43 confirmed or suspected COVID-19 patients admitted to the National Hospital of Neurology and Neurosurgery in the UNITED KingdomMore than a dozen people have been diagnosed with central nervous system inflammation, including nine cases of ADEM,another 10 patientsdeveloped delirium or insanityeight patients had strokes, including one fatal stroke, and another eight had peripheral nerve damageat least two patients also experienced strange behavior shortly after being discharged from the hospitala female patient described in this paper, repeatedly put on and off her coat and began to create the illusion of lions and monkeys appearing in her homeanother female patient became drowsy and eventually needed emergency surgery to relieve pressure on the brainZandi says the full long-term effects of these symptoms may take years to understandmany patients are now too ill to be scanned in a brain scanner, meaning the full extent of neurological symptoms is still unknownin addition, some changes may be more subtle and occur over timeAdrian Owen, a neuroscientist at the University of Western Ontario in Canada who was not involved in the study, is concerned that these symptoms could seriously affect the quality of life of recovering patients"My concern is that we have millions of people with COVID-19 today,"Owen saidIf in a year we have 10 million people who have cognitive impairment..Then this will affect their ability to work and the ability to live in daily life"His fears are precedent-setting, as evidenced by the 1918 flu pandemic, which infected a third of the world's populationin the decades that followed, as many as a million people developed a brain disease called sleeping encephalitis, commonly known as sleeping sicknesssome scholars have linked the two events, although the evidence is still inconclusive"It remains to be seen whether we will observe a large-scale brain injury epidemic associated with the COVID-19 pandemic--- perhaps similar to the --- of sleeping encephalitis that erupted in the 1920s and 1930s following the 1918 influenza pandemic," saidZandi "These researchers are now pushing a larger, possibly global effort to track neurological symptoms." Zandi says health professionals should start incorporating cognitive function into their patient assessments, while paper co-author Ross Paterson, a neurodegenerative specialist at University College London, says early diagnosis is key "Given that COVID-19 has only been around for a few months, we may not yet know what long-term damage this disease will cause," Paterson said doctors need to be aware of possible neurological effects because early diagnosis can improve patient outcomes " (Bioon.com) References: 1.Ross W Paterson et al The emerging spectrum of COVID-19 oedy: clinical, radioc and laboratory sy diss Brain, 2020, doi:10.1093/brain/awaa240.2 Dozens more cases of Case in COVID-19 title title """"!--/ewebeditor:page."